Preventive infection control in cardiac device implantation

Maha Mohamed Mohamed Khalifa1, Michel Lotfy Kolta1, Mazen Tawfik1, Said Khaled1, Emad Fakhry1
1Department of cardiology, Ain Shams University Hospital, 11312, Cairo, Egypt

Tóm tắt

Từ khóa


Tài liệu tham khảo

Mangram AJ, Horan TC, Pearson ML et al (1999) Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 20:250–278 (quiz 279–280)

Milan D, Singh JP (2014) Device implantation and complications: time to recalibrate our expectations? Eur Heart J 35:1167–1168

Connolly SJ, Philippon F, Longtin Y et al (2013) Randomized cluster crossover trials for reliable, efficient, comparative effectiveness testing: design of the Prevention of Arrhythmia Device Infection Trial (PADIT). Can J Cardiol 29:652–658

Sideris S, Kasiakogias A, Pirounaki M et al (2015) Transvenous extraction of cardiac rhythm device leads: a report of the experience from a single referral centre in Greece. Hellenic J Cardiol 56:55–60

Greenspon AJ, Patel JD, Lau E (2011) 16-year trends in the infection burden for pacemakers and implanatble cardioverter-defibrillators in the United States. J Am Coll Cardiol 58:1001–1006

Ann HW, Ahn JY, Jeon YD et al (2015) Incidence of and risk factors for infectious complications in patients with cardiac device implantation. Int J Infect Dis 36:e9–e14

Johansen JB, Jørgensen OD, Møller M et al (2011) Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients. Eur Heart J 32:991–998

Hercé B, Nazeyrollas P, Lesaffre F, Sandras R, Chabert JP, Martin A, Tassan-Mangina S, Bui HT, Metz D (2013) Risk factors for infection of implantable cardiac devices: data from a registry of 2496 patients. Europace 15(1):66–70

Mittal S, Shaw RE, Michel K et al (2014) Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm 11:595–601

Romeyer-Bouchard C, Da Costa A, Dauphinot V et al (2010) Prevalence and risk factors related to infections of cardiac resynchronization therapy devices. Eur Heart J 31:203–210

Tulipan N, Cleves MA (2006) Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection. J Neurosurg 104(1 Suppl):5–8

Ward WG, Cooper JM, Lippert D et al (2014) Glove and gown effects on intraoperative bacterial contamination. Ann Surg 259:591–597

Najjar YW, Al-Wahsh ZM, Hamdan M, Saleh MY (2018) Risk factors of orthopedic surgical site infection in Jordan: a prospective cohort study. Int J Surg Open 15:1–6

Yasuda T, Hasegawa T, Yamato Y et al (2015) Optimal timing of preoperative skin preparation with povidone-iodine for spine surgery: a prospective, randomized controlled study. Asian Spine J 9:423–426

de Oliveira JC, Martinelli M, Nishioka SAD et al (2009) Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2:29–34

Raad D, Irani J, Akl EG, Choueiri S, Azar E, Abboud J, Afif C (2012) Implantable electrophysiological cardiac device infections. Eur J Clin Microbiol Infect Dis 31(11):3015–3021

De Oliveira JC, Martinelli M, D’Avila A, Danik S (2009) Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2: https://doi.org/10.1161/CIRCEP.109.877076

Klug D, Balde M, Pavin D et al (2007) Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators. Circulation 116:1349–1355

Imai K (2016) Perioperative management for the prevention of bacterial infection in cardiac implantable electronic device placement. J Arrhythmia 32:283–286